The House Energy and Commerce Committee yesterday advanced the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (H.R. 6378). The bill, as amended, would authorize $264.6 million in annual funding for the Hospital Preparedness Program, down from $374.7 million currently. The bill also changes the name of HPP to the Healthcare Preparedness and Response Program. The committee did not adopt changes advocated by AHA to increase the HPP funding level to at least $515 million; explicitly permit health systems, academic medical centers and state, metropolitan and regional hospital associations to compete for HPP partnership awards; and formally keep the HPP and Public Health Emergency Preparedness Programs separate under their respective agencies. However, the amended bill does include AHA-supported changes to the Public Health Emergency Fund’s financing and uses, and AHA-supported legislation that would extend liability standards under the Volunteer Protection Act of 1997 to licensed health professionals who volunteer in another state during a disaster.

Related News Articles

Headline
The House Appropriations Committee July 10 voted 31-25 to approve legislation that would provide $185.8 billion in funding for the departments of Labor, Health…
Headline
The Administration for Strategic Preparedness and Response June 25 announced a flu pandemic preparedness and response strategy in response to the threat of…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…